As of June 2022 Amphastar Pharmaceuticals has a market cap of $1.65 Billion. This makes Amphastar Pharmaceuticals the world's 3701th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $1.55 B | 39.25% |
2021 | $1.11 B | 16.68% |
2020 | $0.95 B | 6.31% |
2019 | $0.89 B | -3.18% |
2018 | $0.92 B | 4.9% |
2017 | $0.88 B | 4.34% |
2016 | $0.84 B | 31.81% |
2015 | $0.64 B | 24.08% |
2014 | $0.51 B |
On Jun 28th, 2022 the market cap of Amphastar Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Tonix Pharmaceuticals TNXP | $0.03 B | -98.16% | ๐บ๐ธ USA |
![]() SCYNEXIS SCYX | $0.06 B | -96.29% | ๐บ๐ธ USA |
![]() Marinus Pharmaceuticals MRNS | $0.17 B | -89.49% | ๐บ๐ธ USA |
![]() Agile Therapeutics
AGRX | $7.6 M | -99.54% | ๐บ๐ธ USA |